- The trend backdrop is active with a 45-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
AFT
NZE
Week ended 31 Jul 2026
Weekly Investor Report
AFT Pharmaceuticals Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
4.81 NZD
12.6%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 29.9% above the Trend Line and sits at 98.3% of its 52-week range. The latest completed week returned 12.6%, after a 30.0% four-week move. The latest news-sentiment score is 45/100. Near-term considerations: price is close to its 52-week high.
Setup score
80
out of 100
Latest Close
4.81 NZD
31 Jul 2026
1W Return
12.6%
latest completed week
4W Return
30.0%
short-term follow-through
12W Return
32.3%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
2.9x
vs 13-week average
- Next-week expectancy is negative at 40.21% based on similar historical setup states.
- 4 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
12.6%
Latest completed week; four-week move 30.0%.
Indicator stack
94/95
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 40.21%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
45/100
18 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 29.9% above the Trend Line and sits at 98.3% of its 52-week range. The latest completed week returned 12.6%, after a 30.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8312-week average 0.63
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.83Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 30.0% over four weeks, 32.3% over 12 weeks, and 76.8% over one year. The current trend has remained active for 45 consecutive weeks.
Performance by holding period
Active trend streak45 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.03Latest activity-pressure read.
Pressure change332.9%Four-week change in activity pressure.
Leadership35.99Latest relative-leadership reading.
RS change331.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment45/100
Weighted news tone is neutral across 18 relevant articles.
0 positive · 15 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.8%Distance below the 52-week high.
13-week volatility5.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher10 of 2614 weeks finished lower.
Best week+12.6%Week of 31 Jul.
Worst week-4.6%Week of 15 May.
Latest week+12.6%Week of 31 Jul.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks2
Modest losses11
Sharp losses3
Recent vol5.4%13-week weekly-return volatility.
Base vol5.3%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNZ Healthcare
4-week rank2 / 14
Group average7.0%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD85.7%positive activity pressure
RS57.1%positive relative leadership
Four-week leaders
IndustryNZ Drug Manufacturers - Specialty & Generic
4-week rank2 / 2
Group average35.7%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape77/100
Trend, activity pressure, participation, and risk combine to a 77/100 tape read.
Indicator analysis77/100Latest 12-week confirmation: trend 12/12, activity pressure 10/12, relative leadership 12/12.
Activity pressure 0.83; 4 reversal markers Next-Week ExpectancyNegative 40.21%Next-week expectancy is negative with a 40.21% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment45/100Weighted news tone is neutral across 18 relevant articles.
AFT Pharmaceuticals Chair David Flacks to Retire Within 12 Months as Revenue Hits $254.7 Million Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 4.81 NZD | 12.6% | 3.70 NZD | 3.18 NZD | 1.03 | 35.99 | 366.3K | On |
| 24 Jul 2026 | 4.27 NZD | 9.2% | 3.66 NZD | 3.17 NZD | 0.73 | 21.32 | 394.3K | On |
| 17 Jul 2026 | 3.91 NZD | 0.0% | 3.63 NZD | 3.16 NZD | 0.44 | 12.58 | 85.2K | On |
| 10 Jul 2026 | 3.91 NZD | 5.7% | 3.62 NZD | 3.16 NZD | 0.36 | 12.48 | 120.1K | On |
| 3 Jul 2026 | 3.70 NZD | 0.5% | 3.61 NZD | 3.16 NZD | 0.24 | 8.33 | 31.7K | On |
| 26 Jun 2026 | 3.68 NZD | 0.8% | 3.61 NZD | 3.16 NZD | 0.37 | 9.21 | 8.0K | On |
| 19 Jun 2026 | 3.65 NZD | -4.3% | 3.60 NZD | 3.16 NZD | 0.58 | 8.81 | 90.8K | On |
| 12 Jun 2026 | 3.82 NZD | -1.8% | 3.61 NZD | 3.16 NZD | 0.67 | 15.17 | 4.0K | On |
| 5 Jun 2026 | 3.88 NZD | -0.5% | 3.59 NZD | 3.16 NZD | 0.47 | 20.03 | 10.7K | On |
| 29 May 2026 | 3.90 NZD | 1.3% | 3.57 NZD | 3.15 NZD | 0.33 | 20.62 | 151.5K | On |
| 22 May 2026 | 3.85 NZD | 11.2% | 3.54 NZD | 3.15 NZD | -0.18 | 22.05 | 182.5K | On |
| 15 May 2026 | 3.47 NZD | -4.6% | 3.51 NZD | 3.15 NZD | -0.53 | 10.68 | 111.5K | On |
| 8 May 2026 | 3.64 NZD | 4.6% | 3.51 NZD | 3.15 NZD | -0.58 | 14.79 | 105.5K | On |
| 1 May 2026 | 3.48 NZD | -1.4% | 3.48 NZD | 3.15 NZD | -0.50 | 11.53 | 23.7K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.